ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Regioisomeric Effects on Enhancing p-Type Characteristics of Self-Assembled Molecules in Inverted Perovskite Solar Cells.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Although self-assembled molecules (SAMs) have significantly advanced the development of inverted perovskite solar cells (PSCs), challenges remain in achieving uniform surface potential and reducing interfacial energy losses. Here, we introduced regioisomers with different bromine substitution sites, 3,7-dibromodibenzothiophene-5,5-dioxide (3,7-Br) and 2,8-dibromodibenzothiophene-5,5-dioxide (2.8-Br), as functional modulators for the widely used [4-(3,6dimethyl-9H-carbazole-9-yl)butyl]phosphonic acid (Me-4PACz). Compared with the meta-substituted 3,7-Br, the para-substituted 2,8-Br provides stronger π-π interactions with Me-4PACz, enhanced p-type characteristics, and a more favorable energy level alignment, thereby facilitating hole extraction. Moreover, the electron-withdrawing yet electron-rich sulfonyl moiety and bromo substituents in 2,8-Br interact with perovskite, leading to more effective interfacial defect passivation and suppression of non-radiative recombination. As a result, the power conversion efficiency (PCE) was enhanced from 23.40% to 25.40% after treatment of Me-4PACz with the 2,8-Br. In addition, the 2,8-Br-treated PSCs demonstrated improved light-soaking stability under one sun illumination and thermal stability at 85°C, compared to the control device.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.